Mild cognitive impairment in Parkinson's disease

Journal of Neural Transmission

Volumn 120, Issue 4, 2013, Pages 517-521

  Korczyn, Amos D ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Amnesia; Dementia; Mild cognitive impairment; Parkinson's disease

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; LEVODOPA; RIVASTIGMINE;

CONFERENCE PAPER; HUMAN; HYPERHOMOCYSTEINEMIA; MILD COGNITIVE IMPAIRMENT; PARKINSON DISEASE; PRIORITY JOURNAL; SOCIAL ISOLATION;

AMNESIA; BRAIN; COGNITION; FEMALE; HUMANS; LEWY BODIES; MALE; MILD COGNITIVE IMPAIRMENT; PARKINSON DISEASE;

EID: 84875746579     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-013-1006-0     Document Type: Conference Paper

References (43)

1. Aarsland D, Kurz MW (2010) The epidemiology of dementia associated with Parkinson's disease. Brain Pathol 20:633-639
2. Aarsland D, Laake K, Larsen JP, Janvin C (2002) Donepezil for cognitive impairment in Parkinson's disease: a randomised controlled study. J Neurol Neurosurg Psychiatry 72:708-712 (Pubitemid 34557010)
3. Aarsland D, Andersen K, Larsen JP, Lolk A, Kragh-Sorensen P (2003) Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol 60:387-392 (Pubitemid 36314364)
4. Aarsland D, Bronnick K, Williams-Gray C, Weintraub D, Marder K, Kulisevsky J, Burn D, Barone P, Pagonabarraga J, Allcock L, Santangelo G, Foltynie T, Janvin C, Larsen JP, Barker RA, Emre M (2010) Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis. Neurology 75:1062-1069
5. Adler CH, Caviness JN, Sabbagh MN, Shill HA, Connor DJ, Sue L, Evidente VG, Driver-Dunckley E, Beach TG (2010) Heterogeneous neuropathological findings in Parkinson's disease with mild cognitive impairment. Acta Neuropathol 120:827-828
6. Ash EL, Korczyn AD (2010) Is amnestic mild cognitive impairment a useful concept? Aging Health 7:107-122
7. Balash Y, Korczyn AD (2007) Vascular Parkinsonism. Handb Clin Neurol 84:417-425
8. Ballard C, Ziabreva I, Perry R et al (2006) Differences in neuropathologic characteristics across the Lewy body dementia spectrum. Neurology 67:1931-1934 (Pubitemid 44967366)
9. Bläsi S, Zehnder AE, Berres M, Taylor KI, Spiegel R, Monsch AU (2009) Norms for change in episodic memory as a prerequisite for the diagnosis of mild cognitive impairment (MCI). Neuropsychology 23:189-200
10. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239-259
11. Braak H, Braak E (2000) Pathoanatomy of Parkinson's disease. J Neurol 247:II3-II10
12. Braak H, Del Tredici K, Bratzke H, Hamm-Clement J, Sandmann-Keil D, Rüb U (2002) Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages). J Neurol 249(Suppl 3):III/1-5
13. Cools R, Stefanova E, Barker RA, Robbins TW, Owen AM (2002) Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET. Brain 125:584-594 (Pubitemid 34194413)
14. Dubois B, Pilon B, Lhermitte F, Agid Y (1990) Cholinergic deficiency and frontal dysfunction in Parkinson's disease. Ann Neurol 28:117-121 (Pubitemid 20244511)
15. Emre M, Aarsland D, Albanese A et al (2004) Rivastigmine for dementia associated with Parkinson's disease. N Engl J Med 351:2509-2518 (Pubitemid 39603164)
16. Emre M, Tsolaki M, Bonuccelli U et al (2010) Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 9:969-977
17. Glosser G, Clark C, Freundlich B, Kliner-Krenzel L, Flaherty P, Stern M (1995) A controlled investigation of current and premorbid personality: characteristics of Parkinson's disease patients. Mov Disord 10:201-206
18. Janvin CC, Larsen JP, Aarsland D, Hugdahl K (2006) Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia. Mov Disord 21:1343-1349 (Pubitemid 44613283)
19. Kalaitzakis ME, Pearce RK (2009) The morbid anatomy of dementia in Parkinson's disease. Acta Neuropathol 118:587-598
20. Klein JC, Eggers C, Kalbe E et al (2010) Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo. Neurology 74:885-892
21. Korczyn AD (2002) Mixed dementia - the most common cause of dementia. Ann N Y Acad Sci 977:129-34 (Pubitemid 35418145)
22. Korczyn AD (2011) Should we diagnose MCI in Parkinson disease? J Neural Transm 118:1177
23. Korczyn AD, Gurevich T (2010) Parkinson's disease: before the motor symptoms and beyond. J Neurol Sci 289:2-6
24. Lee JE, Park HJ, Song SK, Sohn YH, Lee JD, Lee PH (2010) Neuroanatomic basis of amnestic MCI differs in patients with and without Parkinson disease. Neurology 75(22):2009-2016
25. Litvan I, Aarsland D, Adler CH, Goldman JG, Kulisevsky J, Mollenhauer B, Rodriguez-Oroz MC, Tröster AI, Weintraub D (2011) MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI. Mov Disord 26:1814-1824
26. Londos E, Passant U, Brun A, Gustafson L (2000) Clinical Lewy body dementia and the impact of vascular components. Int J Geriatr Psychiatry 15:40-49 (Pubitemid 30087913)
27. Nakano I, Hirano A (1984) Parkinson's disease: neuron loss in the nucleus basalis without concomitant Alzheimer's disease. Ann Neurol 15:415-418 (Pubitemid 14145565)
28. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999) Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 56:303-308 (Pubitemid 29120227)
29. Pillon B, Dubois B, Cusimano G, Bonnet AM, Lhermitte 298 F, Agid Y (1989) Does cognitive impairment in Parkinson's disease result from non-dopaminergic lesions? J Neurol Neurosurg Psychiatry 52:201-206 (Pubitemid 19054194)
30. Poewe W, Gerstenbrand F, Ransmayr G, Plörer S (1983) Premorbid personality of Parkinson patients. J Neural Transm Suppl 19:215-224
31. Poletti M, Emre M, Bonuccelli U (2011) Mild cognitive impairment and cognitive reserve in Parkinson's disease. Parkinsonism Relat Disord 17:579-586
32. Reiff J, Schmidt N, Riebe B, Breternitz R, Aldenhoff J, Deuschl G, Witt K (2011) Subthreshold depression in Parkinson's disease. Mov Disord 26:1741-1744
33. Rektorova I, Rektor I, Bares M et al (2005) Cognitive performance in people with Parkinson's disease and mild or moderate depression: effects of dopamine agonists in an add-on to l-dopa therapy. Eur J Neurol 12:9-15
34. Saczynski JS, Beiser A, Seshadri S, Auerbach S, Wolf PA, Au R (2010) Depressive symptoms and risk of dementia: the Framingham Heart Study. Neurology 75:35-41
35. Salganik I, Korczyn A (1990) Risk factors for dementia in Parkinson's disease. Adv Neurol 53:343-347
36. Scatton B, Rouquier L, Javoy-Agid F, Agid Y (1982) Dopamine deficiency in the cerebral cortex in Parkinson disease. Neurology 32(9):1039-1040 (Pubitemid 12049474)
37. Siderowf A, Xie SX, Hurtig H, Weintraub D, Duda J, Chen-Plotkin A, Shaw LM, Van Deerlin V, Trojanowski JQ, Clark C (2010) CSF amyloid {beta} 1-42 predicts cognitive decline in Parkinson disease. Neurology 75(12):1055-1061
38. Treves TA, Chandra V, Korczyn AD (1993a) Parkinson's and Alzheimer's diseases: epidemiological comparison. 1. Descriptive aspects. Neuroepidemiology 12:336-344 (Pubitemid 24030022)
39. Treves TA, Chandra V, Korczyn AD (1993b) Parkinson's and Alzheimer's diseases: epidemiological comparison. 2. Persons at risk. Neuroepidemiology 12:345-349 (Pubitemid 24030023)
40. Uemura Y, Wada-Isoe K, Nakashita S, Nakashima K (2013) Depression and cognitive impairment in patients with mild parkinsonian signs. Acta Neurol Scand. doi: 10.1111/ane.12089
41. Walitza S, Melfsen S, Herhaus G, Scheuerpflug P, Warnke A, Müller T, Lange KW, Gerlach M (2007) Association of Parkinson's disease with symptoms of attention deficit hyperactivity disorder in childhood. J Neural Transm Suppl 72:311-315
42. Weintraub D, Dietz N, Duda JE, Wolk DA, Doshi J, Xie SX, Davatzikos C, Clark CM, Siderowf A (2012) Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease. Brain 135:170-180
43. Werner P, Korczyn AD (2008) Mild cognitive impairment: conceptual, assessment, ethical, and social issues. Clin Interv Aging 3:413-420